Sofía Braga

4.3k total citations · 1 hit paper
52 papers, 1.5k citations indexed

About

Sofía Braga is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Sofía Braga has authored 52 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Sofía Braga's work include HER2/EGFR in Cancer Research (14 papers), Cancer Treatment and Pharmacology (14 papers) and Brain Metastases and Treatment (13 papers). Sofía Braga is often cited by papers focused on HER2/EGFR in Cancer Research (14 papers), Cancer Treatment and Pharmacology (14 papers) and Brain Metastases and Treatment (13 papers). Sofía Braga collaborates with scholars based in Portugal, Spain and Belgium. Sofía Braga's co-authors include Diana P. Saraiva, António Jacinto, M. Guadalupe Cabral, José Luís Passos‐Coelho, Marta Vaz Batista, Martine Piccart, Ahmad Awada, Paula Borralho, Fátima Cardoso and Javier Cortés and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Sofía Braga

50 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial

2022 162 citations José Manuel Pérez-García, Marta Vaz Batista et al. Neuro-Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sofía Braga Portugal	17	931	431	430	357	150	52	1.5k
Roberta Maltoni Italy	21	722 0.8×	338 0.8×	299 0.7×	376 1.1×	104 0.7×	84	1.2k
Véronique D’Hondt France	21	781 0.8×	298 0.7×	335 0.8×	241 0.7×	120 0.8×	83	1.3k
Thibault De La Motte Rouge France	21	479 0.5×	692 1.6×	495 1.2×	329 0.9×	105 0.7×	99	1.7k
Konstantinos Tryfonidis Belgium	20	1.1k 1.2×	326 0.8×	406 0.9×	771 2.2×	202 1.3×	53	1.7k
Gwyn Bebb Canada	20	643 0.7×	360 0.8×	311 0.7×	157 0.4×	129 0.9×	48	1.1k
Salvatore Lopez Italy	25	551 0.6×	369 0.9×	213 0.5×	183 0.5×	195 1.3×	89	1.6k
Carsten Grüllich Germany	25	493 0.5×	557 1.3×	479 1.1×	188 0.5×	264 1.8×	90	1.5k
Edurne Arriola Spain	27	1.4k 1.5×	662 1.5×	931 2.2×	604 1.7×	222 1.5×	122	2.3k
Stefan Kasper Germany	24	885 1.0×	636 1.5×	397 0.9×	190 0.5×	448 3.0×	122	2.0k
Vijayakrishna K. Gadi United States	24	572 0.6×	476 1.1×	312 0.7×	288 0.8×	127 0.8×	87	1.6k

Countries citing papers authored by Sofía Braga

Since Specialization

Citations

This map shows the geographic impact of Sofía Braga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofía Braga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofía Braga more than expected).

Fields of papers citing papers by Sofía Braga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofía Braga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofía Braga. The network helps show where Sofía Braga may publish in the future.

Co-authorship network of co-authors of Sofía Braga

This figure shows the co-authorship network connecting the top 25 collaborators of Sofía Braga. A scholar is included among the top collaborators of Sofía Braga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofía Braga. Sofía Braga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matos, Leonor Vasconcelos de, Elisa Agostinetto, Matteo Lambertini, et al.. (2025). Brain imaging screening in metastatic breast cancer: patients’ and physicians’ perspectives. The Breast. 84. 104558–104558.

Batista, Marta Vaz, José Manuel Pérez-García, Laia Garrigós, et al.. (2024). Abstract PS11-05: Trastuzumab Deruxtecan in patients with HER2[+] or HER2-Low Advanced Breast Cancer and Pathologically Confirmed Leptomeningeal Carcinomatosis: Results from Cohort 5 of the DEBBRAH Study. Cancer Research. 84(9_Supplement). PS11–5. 4 indexed citations

Bowen, Joanne M., Sofía Braga, John Finnie, et al.. (2024). Preclinical and clinical evaluation through serial colonoscopic evaluation of neratinib‐induced diarrhea in HER2‐positive breast cancer—A pilot study. Physiological Reports. 12(16). e70008–e70008. 4 indexed citations

Soares, Leonardo Ribeiro, et al.. (2024). Trastuzumab deruxtecan in human epidermal growth factor receptor 2-positive breast cancer brain metastases: a systematic review and meta-analysis. ESMO Open. 9(2). 102233–102233. 11 indexed citations

Batista, Marta Vaz, José Manuel Pérez-García, Laia Garrigós, et al.. (2024). Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: the DEBBRAH trial. ESMO Open. 9(9). 103699–103699. 11 indexed citations

Pascoal, Carlota, Mylène A. Carrascal, Ana Rita Grosso, et al.. (2023). Sialyl LewisX/A and Cytokeratin Crosstalk in Triple Negative Breast Cancer. Cancers. 15(3). 731–731. 5 indexed citations

Pérez-García, José Manuel, Marta Vaz Batista, Manuel Ruíz Borrego, et al.. (2023). Abstract PD7-02: Trastuzumab Deruxtecan in patients with Unstable Central Nervous System Involvement from HER2-Low Advanced Breast Cancer: The DEBBRAH Trial. Cancer Research. 83(5_Supplement). PD7–2. 6 indexed citations

Braga, Sofía, et al.. (2022). Non-endometrioid endometrial cancer: Analysis of different adjuvant treatment modalities. Cancer Treatment and Research Communications. 32. 100581–100581. 3 indexed citations

Pérez-García, José Manuel, Marta Vaz Batista, Manuel Ruíz‐Borrego, et al.. (2022). Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial. Neuro-Oncology. 25(1). 157–166. 162 indexed citations breakdown →

10.

Costa, Diogo Alpuim, Marta Vaz Batista, Catarina Ribeiro, et al.. (2021). Human Microbiota and Breast Cancer—Is There Any Relevant Link?—A Literature Review and New Horizons Toward Personalised Medicine. Frontiers in Microbiology. 12. 584332–584332. 85 indexed citations

11.

Batista, Marta Vaz, Antonio Llombart‐Cussac, Manuel Ruíz Borrego, et al.. (2021). 330TiP Trastuzumab deruxtecan (T-DXd; DS-8201) in HER2-positive (HER2+) and HER2-low expressing (HER-LE) metastatic breast cancer (MBC) with brain metastases (BM) and/or leptomeningeal carcinomatosis (LMC): DEBBRAH. Annals of Oncology. 32. S509–S510. 3 indexed citations

12.

Braga, Sofía, et al.. (2021). Uterine Sarcomas: A Retrospective Analysis of a Cohort of 62 Patients. Cureus. 13(2). e13349–e13349. 2 indexed citations

13.

Batista, Marta Vaz, et al.. (2019). Brain metastasis of breast cancer: A 10-year single institution retrospective analysis. Annals of Oncology. 30. iii56–iii56. 2 indexed citations

14.

Saraiva, Diana P., António Jacinto, Paula Borralho, Sofía Braga, & M. Guadalupe Cabral. (2018). HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy. Frontiers in Immunology. 9. 2605–2605. 51 indexed citations

15.

Saraiva, Diana P., M. Guadalupe Cabral, António Jacinto, & Sofía Braga. (2017). How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment. ESMO Open. 2(4). e000208–e000208. 46 indexed citations

16.

Costa, Filipa Alves da, et al.. (2016). Sexual Dysfunction in Breast Cancer Survivors: Cross-Cultural Adaptation of the Sexual Activity Questionnaire for Use in Portugal. Acta Médica Portuguesa. 29(9). 533–541. 8 indexed citations

17.

Braga, Sofía, Joana Cardoso, Saudade André, et al.. (2016). Does Hypoxic Response Mediate Primary Resistance to Sunitinib in Untreated Locally Advanced Breast Cancer?. Current Cancer Drug Targets. 17(1). 62–73. 4 indexed citations

18.

Baselga, José, Patricia Gómez, Richard Greil, et al.. (2013). Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer. Journal of Clinical Oncology. 31(20). 2586–2592. 298 indexed citations

19.

Oliveira, Mafalda, et al.. (2011). Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab. Breast Cancer Research and Treatment. 127(3). 841–844. 52 indexed citations

20.

Bogaerts, Jan, Fátima Cardoso, Marc Buyse, et al.. (2006). Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial. Nature Clinical Practice Oncology. 3(10). 540–551. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact